de Thé H - Search Results

1

Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML).

Djamai H, Berrou J, Dupont M, Coudé MM, Delord M, Clappier E, Marceau-Renaut A, Kaci A, Raffoux E, Itzykson R, Berthier C, Wu HC, Hleihel R, Bazarbachi A, de Thé H, Baruchel A, Gardin C, Dombret H, Braun T. Djamai H, et al. Among authors: de the h. Biomedicines. 2021 Nov 17;9(11):1704. doi: 10.3390/biomedicines9111704. Biomedicines. 2021. PMID: 34829934 Free PMC article.

2

PML protein expression in hematopoietic and acute promyelocytic leukemia cells.

Daniel MT, Koken M, Romagné O, Barbey S, Bazarbachi A, Stadler M, Guillemin MC, Degos L, Chomienne C, de Thé H. Daniel MT, et al. Among authors: de the h. Blood. 1993 Sep 15;82(6):1858-67. Blood. 1993. PMID: 8400236 Free article.

3

Arsenic-interferon-alpha-triggered apoptosis in HTLV-I transformed cells is associated with tax down-regulation and reversal of NF-kappa B activation.

El-Sabban ME, Nasr R, Dbaibo G, Hermine O, Abboushi N, Quignon F, Ameisen JC, Bex F, de Thé H, Bazarbachi A. El-Sabban ME, et al. Among authors: de the h. Blood. 2000 Oct 15;96(8):2849-55. Blood. 2000. PMID: 11023521 Free article.

4

Retinoic acid dramatically enhances the arsenic trioxide-induced cell cycle arrest and apoptosis in retinoic acid receptor alpha-positive human T-cell lymphotropic virus type-I-transformed cells.

Darwiche N, El-Sabban M, Bazzi R, Nasr R, Al-Hashimi S, Hermine O, de Thé H, Bazarbachi A. Darwiche N, et al. Among authors: de the h. Hematol J. 2001;2(2):127-35. doi: 10.1038/sj/thj/6200098. Hematol J. 2001. PMID: 11424005

5

Human T-cell lymphotropic virus type 1-transformed cells induce angiogenesis and establish functional gap junctions with endothelial cells.

El-Sabban ME, Merhi RA, Haidar HA, Arnulf B, Khoury H, Basbous J, Nijmeh J, de Thé H, Hermine O, Bazarbachi A. El-Sabban ME, et al. Among authors: de the h. Blood. 2002 May 1;99(9):3383-9. doi: 10.1182/blood.v99.9.3383. Blood. 2002. PMID: 11964307 Free article.

6

In vivo activation of cAMP signaling induces growth arrest and differentiation in acute promyelocytic leukemia.

Guillemin MC, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V, Zhu J, Janin A, Daniel MT, Gourmel B, Degos L, Dombret H, Lanotte M, De Thé H. Guillemin MC, et al. Among authors: de the h. J Exp Med. 2002 Nov 18;196(10):1373-80. doi: 10.1084/jem.20021129. J Exp Med. 2002. PMID: 12438428 Free PMC article.

7

Arsenic/interferon specifically reverses 2 distinct gene networks critical for the survival of HTLV-1-infected leukemic cells.

Nasr R, Rosenwald A, El-Sabban ME, Arnulf B, Zalloua P, Lepelletier Y, Bex F, Hermine O, Staudt L, de Thé H, Bazarbachi A. Nasr R, et al. Among authors: de the h. Blood. 2003 Jun 1;101(11):4576-82. doi: 10.1182/blood-2002-09-2986. Epub 2003 Jan 30. Blood. 2003. PMID: 12560223 Free article.

8

Combined treatment with arsenic trioxide and all-trans-retinoic acid in patients with relapsed acute promyelocytic leukemia.

Raffoux E, Rousselot P, Poupon J, Daniel MT, Cassinat B, Delarue R, Taksin AL, Réa D, Buzyn A, Tibi A, Lebbé G, Cimerman P, Chomienne C, Fermand JP, de Thé H, Degos L, Hermine O, Dombret H. Raffoux E, et al. Among authors: de the h. J Clin Oncol. 2003 Jun 15;21(12):2326-34. doi: 10.1200/JCO.2003.01.149. J Clin Oncol. 2003. PMID: 12805334 Clinical Trial.

9

N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.

Darwiche N, Hatoum A, Dbaibo G, Kadara H, Nasr R, Abou-Lteif G, Bazzi R, Hermine O, de Thé H, Bazarbachi A. Darwiche N, et al. Among authors: de the h. Leukemia. 2004 Mar;18(3):607-15. doi: 10.1038/sj.leu.2403245. Leukemia. 2004. PMID: 14712289

10

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.

Hermine O, Dombret H, Poupon J, Arnulf B, Lefrère F, Rousselot P, Damaj G, Delarue R, Fermand JP, Brouet JC, Degos L, Varet B, de Thé H, Bazarbachi A. Hermine O, et al. Among authors: de the h. Hematol J. 2004;5(2):130-4. doi: 10.1038/sj.thj.6200374. Hematol J. 2004. PMID: 15048063 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters